© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
Expert rheumatologists work together to elucidate the current treatment paradigm for patients with systemic lupus erythematous or idiopathic inflammatory myopathies.
October 14th 2021
Expert rheumatologists share an overview of the characteristics of SARDs, covering rare disease status, quality of life, and associated comorbidities.
An overview of systemic lupus erythematous including possible causes, prevalence, symptomology, diagnosis, and the goals of therapy.
October 21st 2021
A brief review of idiopathic inflammatory myopathies, ranging from pathology to the goals of treatment.
Comprehensive insight on the treatment armamentarium for systemic lupus erythematous and nuances in selecting optimal therapy.
October 28th 2021
Experts take a dive into available therapies and optimal treatment strategies for idiopathic inflammatory myopathies.
Considerations for the role of telemedicine in caring for patients with SARDs, with deference to the challenges of an accurate patient evaluation.
November 4th 2021
W. Hayes Wilson, MD, and Kostas Botsoglou, MD, reflect on the importance of patient education and advocacy in managing SARDs.
Shared insight on the importance of educating patients with SARDs on the value of COVID-19 vaccination.
November 11th 2021
Closing out their discussion, experts highlight practical advice for caring for patients with SARDs in the current treatment landscape.
Increased Risk of Eating Disorders, ARFID Among Cystic Fibrosis Population
Sleep Disorder May Increase Short-Term Risk for Late-Onset Dementia
FDA Approves Baloxavir Marboxil to Treat, Prevent Flu in Younger At-Risk Children